Silvia Noemi Tenembaum
Silvia Noemi Tenembaum publishes mostly in Pathology and Forensic Medicine, Neurology and Rheumatology, on topics such as Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Systemic Lupus Erythematosus Research.
- World rank
- #420,477 of 7,710,434 ranked researchers
- Rank in Argentina
- #458 of 38,473
- Works
- 97
- Citations
- 9.1k
- Citations per work
- 93.7
What does Silvia Noemi Tenembaum research?
Silvia Noemi Tenembaum's work is mostly in Medicine (63%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6162.8%
- Medicine6162.8%
- Everything else2930.4%
- Life Sciences76.8%
- 1Pathology and Forensic Medicine26% of their works
- 2Neurology22% of their works
- 3Rheumatology7% of their works
- 4Immunology7% of their works
- 5Hematology4% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Systemic Lupus Erythematosus Research
- Autoimmune Neurological Disorders and Treatments
- Autoimmune and Inflammatory Disorders Research
- Viral Infections and Immunology Research
- Polyomavirus and related diseases
- Systemic Sclerosis and Related Diseases
Which keywords describe Silvia Noemi Tenembaum's research?
The keywords of their largest research topics: Cognitive Impairment, Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Neurological Disorders, Treatment, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Guillain-Barré Syndrome.
- Viral Infection
- Polyomavirus
- Merkel Cell Carcinoma
- Juvenile Idiopathic Arthritis
- Paraneoplastic Syndromes
- Immunosuppressive Therapy
- Antiphospholipid Syndrome
- Guillain-Barré Syndrome
- Treatment
- Neuromyelitis Optica
- Diagnostic Criteria
- Cognitive Impairment
- Multiple Sclerosis
- Neurological Disorders
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Autoantibodies
- Systemic Lupus Erythematosus
- Anti-NMDA Receptor Encephalitis
- Hemophagocytic Lymphohistiocytosis
- Fibrosis
- Myocarditis
- Systemic Sclerosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Cognitive Impairment672 topics
- Diagnostic Criteria672 topics
- Multiple Sclerosis581 topic
- Neuromyelitis Optica581 topic
- Neurological Disorders502 topics
- Treatment462 topics
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy411 topic
- Guillain-Barré Syndrome411 topic
- Autoantibodies253 topics
- Antiphospholipid Syndrome111 topic
- Systemic Lupus Erythematosus111 topic
- Immunosuppressive Therapy102 topics
- Anti-NMDA Receptor Encephalitis91 topic
- Paraneoplastic Syndromes91 topic
- Hemophagocytic Lymphohistiocytosis81 topic
- Juvenile Idiopathic Arthritis81 topic
- Fibrosis51 topic
- Merkel Cell Carcinoma51 topic
- Myocarditis51 topic
- Polyomavirus51 topic
- Systemic Sclerosis51 topic
- Viral Infection51 topic
Where does Silvia Noemi Tenembaum work?
Silvia Noemi Tenembaum's main affiliation in the publication record is Garrahan Hospital, Argentina.
How many publications and citations does Silvia Noemi Tenembaum have?
OpenAlex counts 97 works and 9,091 citations for Silvia Noemi Tenembaum, an h-index of 34, ranking #420,477 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Silvia Noemi Tenembaum. Posts are plain text and can be reported.